AstraZeneca halted its Phase 3 coronavirus vaccine trial earlier this week following a severe reaction that may or may not have been induced by the vaccine. CEO Pascal Soriot addressed the matter in >>

AstraZeneca confirmed that the Oxford vaccine’s Phase 3 trial was paused as it investigates the matter to determine what caused a serious adverse reaction in a volunteer in the UK. A report says >>

One of the coronavirus vaccine candidates that has shown encouraging results is the one being developed at Oxford, which could be ready for emergency use this September. However, researchers are running into a >>